Literature DB >> 25091059

Irritable bowel syndrome: a comparison of subtypes.

Nicolas G Rey de Castro1, Vivien Miller, Helen R Carruthers, Peter J Whorwell.   

Abstract

BACKGROUND AND AIM: Irritable bowel syndrome (IBS) is traditionally divided into subtypes depending on the bowel habit abnormality, but there is little clarity in the literature about whether these subtypes differ symptomatically or psychologically. Furthermore, there are conflicting reports on the relationship between symptom severity and psychological status. The aim of this study was to address these issues in a large cohort of patients defined by bowel habit.
METHODS: One thousand IBS patients were divided into diarrhea (IBS-D), constipation (IBS-C), and mixed (IBS-M) bowel habit subtypes and completed a series of validated questionnaires capturing symptom severity, non-colonic symptomatology (somatization), quality of life, and anxiety or depression levels. Comparisons were made using SPSS version 20.
RESULTS: There were no significant differences between the three subtypes with respect to symptom severity, abdominal pain intensity, non-colonic symptomatology, quality of life, and anxiety or depression scores (all Ps > 0.05). In addition, there was only a small but statistically significant correlation between IBS symptom severity and both anxiety or depression, as well as quality of life (highest r = 0.34), while the relationship between somatization and disease severity was moderate (r = 0.42).
CONCLUSION: This study suggests that there are no differences in the symptom profiles and anxiety or depression scores between different subtypes of IBS. In addition, anxiety and depression do not appear to be strongly associated with symptom severity, although this does not exclude the possible interplay between these and other psychological drivers of severity, such as poor coping skills.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  irritable bowel syndrome; psychological factors; severity; subtypes

Mesh:

Year:  2015        PMID: 25091059     DOI: 10.1111/jgh.12704

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Symptom Comparisons Between Asian American and White American Women With Irritable Bowel Syndrome.

Authors:  Claire Jungyoun Han; Chaoqun Dong; Monica E Jarrett; Margaret M Heitkemper
Journal:  Gastroenterol Nurs       Date:  2018 May/Jun       Impact factor: 0.978

2.  Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.

Authors:  Aleksandra Grozić; Keaton Coker; Christopher M Dussik; Marya S Sabir; Zhela Sabir; Arianna Bradley; Lin Zhang; Jin Park; Steven Yale; Ichiro Kaneko; Maryam Hockley; Lucinda A Harris; Tisha N Lunsford; Todd R Sandrin; Peter W Jurutka
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 3.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

Review 4.  Extraintestinal manifestations in irritable bowel syndrome: A systematic review.

Authors:  Bodil Ohlsson
Journal:  Therap Adv Gastroenterol       Date:  2022-08-09       Impact factor: 4.802

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.